De persberichten worden uitgegeven door FUJIFILM Corporation in Japan.
Fujifilm doet geen toezegging dat de producten die worden vermeld in deze persberichten in alle landen en regio’s commercieel verkrijgbaar zijn.
Houd er rekening mee dat de inhoud van deze website actueel is vanaf de datum van het persbericht en zonder voorafgaande kennisgeving kan worden gewijzigd. Informatie in elk bericht, zoals de beschikbaarheid van het product, specificatie, prijzen, contacten, is actueel op het moment van publicatie.
- sep 25, 2025
- FUJIFILM Biotechnologies Celebrates the Grand Opening of its Commercial-Scale Cell Culture Manufacturing Site in North Carolina
- sep 19, 2025
- FUJIFILM Biotechnologies Expands Strategic Partnership with argenx to Include U.S. Manufacturing Operations
- jun 2, 2025
- Fujifilm Rebrands Life Sciences Companies to Strengthen Position as Strategic Partners for Life, Offering End-to-End Solutions
- apr 22, 2025
- FUJIFILM Diosynth Biotechnologies and Regeneron Sign a 10-year U.S. Manufacturing Agreement Valued at Over $3 Billion
- nov 5, 2024
- FUJIFILM Diosynth Biotechnologies Launches First Phase of Global CDMO Ecosystem Expansion
- apr 12, 2024
- Fujifilm to Invest Additional $1.2 Billion to Expand its Large-Scale Cell Culture CDMO Business in North Carolina
- feb 29, 2024
- FUJIFILM Diosynth Biotechnologies Announces Renewable Energy PPA with Better Energy for Denmark Manufacturing Site
- dec 5, 2023
- Fujifilm to Invest USD 200 Million to Expand Cell Therapy Development and Manufacturing Capabilities
- nov 8, 2023
- FUJIFILM Diosynth Biotechnologies Announces First Tenant for New Manufacturing Facility
- jun 6, 2023
- Fujifilm to Enhance Commercial Presence in Asia for Biologics and Advanced Therapies Contract Services
- mrt 31, 2023
- Transfer of FUJIFILM Healthcare Systems’ electronic medical record and medical-receipt systems related business to PHC Holdings’ subsidiary
- dec 20, 2022
- Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to acquire the company’s Digital Pathology Business
- dec 14, 2022
- Fujifilm Invests in PhenoVista Biosciences from its Life Sciences Corporate Venture Capital Fund










